Shares of Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating) have earned a consensus rating of “Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued ratings on […]
Stock analysts at Stifel Nicolaus initiated coverage on shares of Disc Medicine Opco (NASDAQ:IRON – Get Rating) in a report issued on Thursday, The Fly reports. The brokerage set a “buy” rating on the stock. Several other research analysts also recently issued reports on the company. SVB Securities assumed coverage on Disc Medicine Opco in […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) and Sigilon Therapeutics (NASDAQ:SGTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Volatility and Risk Disc Medicine Opco has a […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) and ProPhase Labs (NASDAQ:PRPH – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability. Volatility and Risk Disc Medicine Opco has a […]
UBS Group AG bought a new position in Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,115 shares of the company’s stock, valued at approximately $142,000. UBS Group AG owned approximately […]